R01 HL108307/HL/NHLBI NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
2012	1
2013	4
2014	3
2015	2
2016	1
2017	1
2019	1
2020	1
2023	1
2024	0

1

Impact of Donor Statin Treatment on Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.

Rashid N, Gooley T, Furlong T, Lee SJ, Martin PJ, Storb R, Mielcarek M. Rashid N, et al. Transplant Cell Ther. 2023 Nov;29(11):701.e1-701.e8. doi: 10.1016/j.jtct.2023.08.027. Epub 2023 Aug 30. Transplant Cell Ther. 2023. PMID: 37657769

2

Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts.

McDonald GB, Sandmaier BM, Mielcarek M, Sorror M, Pergam SA, Cheng GS, Hingorani S, Boeckh M, Flowers MD, Lee SJ, Appelbaum FR, Storb R, Martin PJ, Deeg HJ, Schoch G, Gooley TA. McDonald GB, et al. Ann Intern Med. 2020 Feb 18;172(4):229-239. doi: 10.7326/M19-2936. Epub 2020 Jan 21. Ann Intern Med. 2020. PMID: 31958813 Free PMC article.

3

Limited Utility of Outpatient Surveillance Blood Cultures in Hematopoietic Cell Transplant Recipients on High-Dose Steroids for Treatment of Acute Graft-versus-Host-Disease.

Stohs E, Chow VA, Liu C, Bourassa L, Miles-Jay A, Knight J, Sweet A, Storer BE, Mielcarek M, Pergam SA. Stohs E, et al. Biol Blood Marrow Transplant. 2019 Jun;25(6):1247-1252. doi: 10.1016/j.bbmt.2019.01.031. Epub 2019 Feb 1. Biol Blood Marrow Transplant. 2019. PMID: 30711778 Free PMC article.

4

Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myeloma.

Green DJ, Maloney DG, Storer BE, Sandmaier BM, Holmberg LA, Becker PS, Fang M, Martin PJ, Georges GE, Bouvier ME, Storb R, Mielcarek M. Green DJ, et al. Blood Adv. 2017 Nov 9;1(24):2247-2256. doi: 10.1182/bloodadvances.2017010686. eCollection 2017 Nov 14. Blood Adv. 2017. PMID: 29296873 Free PMC article.

5

Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation.

Mielcarek M, Furlong T, O'Donnell PV, Storer BE, McCune JS, Storb R, Carpenter PA, Flowers ME, Appelbaum FR, Martin PJ. Mielcarek M, et al. Blood. 2016 Mar 17;127(11):1502-8. doi: 10.1182/blood-2015-10-672071. Epub 2016 Jan 13. Blood. 2016. PMID: 26764356 Free PMC article. Clinical Trial.

6

Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial.

Mielcarek M, Furlong T, Storer BE, Green ML, McDonald GB, Carpenter PA, Flowers ME, Storb R, Boeckh M, Martin PJ. Mielcarek M, et al. Haematologica. 2015 Jun;100(6):842-8. doi: 10.3324/haematol.2014.118471. Epub 2015 Feb 14. Haematologica. 2015. PMID: 25682602 Free PMC article. Clinical Trial.

7

The association between donor and recipient statin use and infections after allogeneic hematopoietic cell transplantation.

Seo S, Boeckh M, Storer BE, Schubert MM, Rotta M, Sandmaier BM, Mielcarek M. Seo S, et al. Bone Marrow Transplant. 2015 Mar;50(3):444-8. doi: 10.1038/bmt.2014.279. Epub 2015 Jan 19. Bone Marrow Transplant. 2015. PMID: 25599167 Free PMC article.

8

Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and fludarabine conditioning.

Kanakry CG, O'Donnell PV, Furlong T, de Lima MJ, Wei W, Medeot M, Mielcarek M, Champlin RE, Jones RJ, Thall PF, Andersson BS, Luznik L. Kanakry CG, et al. J Clin Oncol. 2014 Nov 1;32(31):3497-505. doi: 10.1200/JCO.2013.54.0625. Epub 2014 Sep 29. J Clin Oncol. 2014. PMID: 25267759 Free PMC article. Clinical Trial.

9

Langerhans cell homeostasis and turnover after nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation.

Mielcarek M, Kirkorian AY, Hackman RC, Price J, Storer BE, Wood BL, Leboeuf M, Bogunovic M, Storb R, Inamoto Y, Flowers ME, Martin PJ, Collin M, Merad M. Mielcarek M, et al. Transplantation. 2014 Sep 15;98(5):563-8. doi: 10.1097/TP.0000000000000097. Transplantation. 2014. PMID: 24717220 Free PMC article. Clinical Trial.

10

Response endpoints and failure-free survival after initial treatment for acute graft-versus-host disease.

Inamoto Y, Martin PJ, Storer BE, Mielcarek M, Storb RF, Carpenter PA. Inamoto Y, et al. Haematologica. 2014 Feb;99(2):385-91. doi: 10.3324/haematol.2013.093062. Epub 2013 Sep 20. Haematologica. 2014. PMID: 24056814 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

14 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year